Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 109464 entries
Sorted by: Best Match Show Resources per page
[Effect of thymostimulin on chemotherapy-induced changes in lymphocyte subset distribution. A longitudinal study in patients with primary inoperable oropharyngeal cancers].

Onkologie

Schuff-Werner P, Löhr G, Rauschning W, Schröder M, Musil J, Nagel GA.
PMID: 3309757
Onkologie. 1987 Jun;10(3):17-21.

20 patients with primarily inoperable squamous cell carcinoma of the head and neck were treated with 2 cycles of chemotherapy prior to surgical treatment. The lymphocyte subsets were determined prior to chemotherapy, as well as directly after and 3...

Cite
Schuff-Werner P, Löhr G, Rauschning W, et al. Einfluss von Thymostimulin auf die Chemotherapie-induzierte Veränderung der Lymphozytensubpopulationsverteilung. Eine Langzeituntersuchung an Patienten mit primär inoperablem Oropharynxkarzinom. [Effect of thymostimulin on chemotherapy-induced changes in lymphocyte subset distribution. A longitudinal study in patients with primary inoperable oropharyngeal cancers]. Onkologie. 1987;10(3):17-21
Schuff-Werner, P., Löhr, G., Rauschning, W., Schröder, M., Musil, J., & Nagel, G. A. (1987). Einfluss von Thymostimulin auf die Chemotherapie-induzierte Veränderung der Lymphozytensubpopulationsverteilung. Eine Langzeituntersuchung an Patienten mit primär inoperablem Oropharynxkarzinom. [Effect of thymostimulin on chemotherapy-induced changes in lymphocyte subset distribution. A longitudinal study in patients with primary inoperable oropharyngeal cancers]. Onkologie, 10(3), 17-21.
Schuff-Werner, P, et al. "Einfluss von Thymostimulin auf die Chemotherapie-induzierte Veränderung der Lymphozytensubpopulationsverteilung. Eine Langzeituntersuchung an Patienten mit primär inoperablem Oropharynxkarzinom." [Effect of thymostimulin on chemotherapy-induced changes in lymphocyte subset distribution. A longitudinal study in patients with primary inoperable oropharyngeal cancers]. Onkologie vol. 10,3 (1987): 17-21.
Schuff-Werner P, Löhr G, Rauschning W, Schröder M, Musil J, Nagel GA. Einfluss von Thymostimulin auf die Chemotherapie-induzierte Veränderung der Lymphozytensubpopulationsverteilung. Eine Langzeituntersuchung an Patienten mit primär inoperablem Oropharynxkarzinom. [Effect of thymostimulin on chemotherapy-induced changes in lymphocyte subset distribution. A longitudinal study in patients with primary inoperable oropharyngeal cancers]. Onkologie. 1987 Jun;10(3):17-21. German. PMID: 3309757.
Copy Download .nbib Format: NLM
Pharmacokinetics of mitoxantrone in humans following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapy.

Cancer chemotherapy and pharmacology

Van Belle SJ, de Planque MM, Smith IE, van Oosterom AT, Schoemaker TJ, Deneve W, McVie JG.
PMID: 3757156
Cancer Chemother Pharmacol. 1986;18(1):27-32. doi: 10.1007/BF00253059.

This study describes the pharmacokinetics of mitoxantrone determined by a sensitive and specific HPLC-method. The time-concentration curves of i.v.-treated patients (15 mg/m2 over 30 min) correspond to a three-compartment model with a T1/2 alpha of 12 min, a T1/2...

Cite
Van Belle SJ, de Planque MM, Smith IE, et al. Pharmacokinetics of mitoxantrone in humans following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapy. Cancer Chemother Pharmacol. 1986;18(1):27-32doi: 10.1007/BF00253059.
Van Belle, S. J., de Planque, M. M., Smith, I. E., van Oosterom, A. T., Schoemaker, T. J., Deneve, W., & McVie, J. G. (1986). Pharmacokinetics of mitoxantrone in humans following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapy. Cancer chemotherapy and pharmacology, 18(1), 27-32. https://doi.org/10.1007/BF00253059
Van Belle, S J, et al. "Pharmacokinetics of mitoxantrone in humans following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapy." Cancer chemotherapy and pharmacology vol. 18,1 (1986): 27-32. doi: https://doi.org/10.1007/BF00253059
Van Belle SJ, de Planque MM, Smith IE, van Oosterom AT, Schoemaker TJ, Deneve W, McVie JG. Pharmacokinetics of mitoxantrone in humans following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapy. Cancer Chemother Pharmacol. 1986;18(1):27-32. doi: 10.1007/BF00253059. PMID: 3757156.
Copy Download .nbib Format: NLM
Plasma histamine and serum pepsinogen I concentrations in chronic myelogenous leukaemia.

Acta medica Scandinavica

Välimäki M, Vuopio P, Salaspuro M.
PMID: 3856379
Acta Med Scand. 1985;217(1):89-93. doi: 10.1111/j.0954-6820.1985.tb01640.x.

A male patient with multiple gastroduodenal ulcers and gastric hypersecretion due to hyperhistaminaemia associated with extreme basophilia occurring in chronic myelogenous leukaemia (CML) is described. In addition, plasma histamine levels and serum pepsinogen I concentrations, reflecting gastric acid secretion,...

Cite
Välimäki M, Vuopio P, Salaspuro M. Plasma histamine and serum pepsinogen I concentrations in chronic myelogenous leukaemia. Acta Med Scand. 1985;217(1):89-93doi: 10.1111/j.0954-6820.1985.tb01640.x.
Välimäki, M., Vuopio, P., & Salaspuro, M. (1985). Plasma histamine and serum pepsinogen I concentrations in chronic myelogenous leukaemia. Acta medica Scandinavica, 217(1), 89-93. https://doi.org/10.1111/j.0954-6820.1985.tb01640.x
Välimäki, M, et al. "Plasma histamine and serum pepsinogen I concentrations in chronic myelogenous leukaemia." Acta medica Scandinavica vol. 217,1 (1985): 89-93. doi: https://doi.org/10.1111/j.0954-6820.1985.tb01640.x
Välimäki M, Vuopio P, Salaspuro M. Plasma histamine and serum pepsinogen I concentrations in chronic myelogenous leukaemia. Acta Med Scand. 1985;217(1):89-93. doi: 10.1111/j.0954-6820.1985.tb01640.x. PMID: 3856379.
Copy Download .nbib Format: NLM
Gallbladder adenocarcinoma: the prognostic significance of histologic grade.

Journal of surgical oncology

Johnson LA, Lavin PT, Dayal YY, Geller SA, Doos WG, Cooper HS, Gerber JE, Masse SR, Weiland LH, Moertel CG.
PMID: 3807370
J Surg Oncol. 1987 Jan;34(1):16-8. doi: 10.1002/jso.2930340105.

Gallbladder adenocarcinoma (GBA) postresection 5-year survival rates are less than 5%, but when histologically confined to the mucosa or submucosa, survival rates of 64% (5 years) and 44% (10 years) have been reported. Whether any other histologic features of...

Cite
Johnson LA, Lavin PT, Dayal YY, et al. Gallbladder adenocarcinoma: the prognostic significance of histologic grade. J Surg Oncol. 1987;34(1):16-8doi: 10.1002/jso.2930340105.
Johnson, L. A., Lavin, P. T., Dayal, Y. Y., Geller, S. A., Doos, W. G., Cooper, H. S., Gerber, J. E., Masse, S. R., Weiland, L. H., & Moertel, C. G. (1987). Gallbladder adenocarcinoma: the prognostic significance of histologic grade. Journal of surgical oncology, 34(1), 16-8. https://doi.org/10.1002/jso.2930340105
Johnson, L A, et al. "Gallbladder adenocarcinoma: the prognostic significance of histologic grade." Journal of surgical oncology vol. 34,1 (1987): 16-8. doi: https://doi.org/10.1002/jso.2930340105
Johnson LA, Lavin PT, Dayal YY, Geller SA, Doos WG, Cooper HS, Gerber JE, Masse SR, Weiland LH, Moertel CG. Gallbladder adenocarcinoma: the prognostic significance of histologic grade. J Surg Oncol. 1987 Jan;34(1):16-8. doi: 10.1002/jso.2930340105. PMID: 3807370.
Copy Download .nbib Format: NLM
[Evaluation of the effectiveness of preoperative local thermoradio- and thermochemotherapy of breast cancer using thermography].

Meditsinskaia radiologiia

Zhovimir VK, Mazurin VIa.
PMID: 3807701
Med Radiol (Mosk). 1987 Jan;32(1):45-7.

The efficacy of combined preoperative local MWF-hyperthermia of breast cancer was difficult to assess because within a short period of treatment tumor remained clinically unchanged. At the same time it resulted in the death of cancer cells and blood...

Cite
Zhovimir VK, Mazurin VIa. Otsenka éffektivnosti predoperatsionnoĭ lokal'noĭ termoradio- i termokhimioterapii raka molochnoĭ zhelezy pri pomoshchi termografii. [Evaluation of the effectiveness of preoperative local thermoradio- and thermochemotherapy of breast cancer using thermography]. Med Radiol (Mosk). 1987;32(1):45-7
Zhovimir, V. K., & Mazurin, V. I. a. (1987). Otsenka éffektivnosti predoperatsionnoĭ lokal'noĭ termoradio- i termokhimioterapii raka molochnoĭ zhelezy pri pomoshchi termografii. [Evaluation of the effectiveness of preoperative local thermoradio- and thermochemotherapy of breast cancer using thermography]. Meditsinskaia radiologiia, 32(1), 45-7.
Zhovimir, V K, and Mazurin, V Ia. "Otsenka éffektivnosti predoperatsionnoĭ lokal'noĭ termoradio- i termokhimioterapii raka molochnoĭ zhelezy pri pomoshchi termografii." [Evaluation of the effectiveness of preoperative local thermoradio- and thermochemotherapy of breast cancer using thermography]. Meditsinskaia radiologiia vol. 32,1 (1987): 45-7.
Zhovimir VK, Mazurin VIa. Otsenka éffektivnosti predoperatsionnoĭ lokal'noĭ termoradio- i termokhimioterapii raka molochnoĭ zhelezy pri pomoshchi termografii. [Evaluation of the effectiveness of preoperative local thermoradio- and thermochemotherapy of breast cancer using thermography]. Med Radiol (Mosk). 1987 Jan;32(1):45-7. Russian. PMID: 3807701.
Copy Download .nbib Format: NLM
Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas.

Israel journal of medical sciences

Sulkes A, Uziely B, Isacson R, Brufman G, Biran S.
PMID: 3204009
Isr J Med Sci. 1988 Sep-Oct;24(9):604-10.

Twenty-nine evaluable patients with metastatic carcinomatosis in whom initial workup failed to reveal the primary site were entered into this trial. Patients with histological evidence of adenocarcinoma (n = 15) received FAM, while patients with anaplastic carcinomas (n =...

Cite
Sulkes A, Uziely B, Isacson R, et al. Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas. Isr J Med Sci. 1988;24(9):604-10
Sulkes, A., Uziely, B., Isacson, R., Brufman, G., & Biran, S. (1988). Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas. Israel journal of medical sciences, 24(9), 604-10.
Sulkes, A, et al. "Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas." Israel journal of medical sciences vol. 24,9 (1988): 604-10.
Sulkes A, Uziely B, Isacson R, Brufman G, Biran S. Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas. Isr J Med Sci. 1988 Sep-Oct;24(9):604-10. PMID: 3204009.
Copy Download .nbib Format: NLM
Autologous bone marrow transplantation in adult ALL. A French survey of 32 patients.

Revue francaise de transfusion et immuno-hematologie

Flesch M, Hervé P.
PMID: 3912926
Rev Fr Transfus Immunohematol. 1985 Nov;28(5):489-502. doi: 10.1016/s0338-4535(85)80023-4.

No abstract available.

Cite
Flesch M, Hervé P. Autologous bone marrow transplantation in adult ALL. A French survey of 32 patients. Rev Fr Transfus Immunohematol. 1985;28(5):489-502doi: 10.1016/s0338-4535(85)80023-4.
Flesch, M., & Hervé, P. (1985). Autologous bone marrow transplantation in adult ALL. A French survey of 32 patients. Revue francaise de transfusion et immuno-hematologie, 28(5), 489-502. https://doi.org/10.1016/s0338-4535(85)80023-4
Flesch, M, and Hervé, P. "Autologous bone marrow transplantation in adult ALL. A French survey of 32 patients." Revue francaise de transfusion et immuno-hematologie vol. 28,5 (1985): 489-502. doi: https://doi.org/10.1016/s0338-4535(85)80023-4
Flesch M, Hervé P. Autologous bone marrow transplantation in adult ALL. A French survey of 32 patients. Rev Fr Transfus Immunohematol. 1985 Nov;28(5):489-502. doi: 10.1016/s0338-4535(85)80023-4. PMID: 3912926.
Copy Download .nbib Format: NLM
Adjuvant therapy for colorectal cancer: the NSABP clinical trials.

Advances in experimental medicine and biology

Wolmark N.
PMID: 3073660
Adv Exp Med Biol. 1988;244:261-6. doi: 10.1007/978-1-4684-5607-3_28.

No abstract available.

Cite
Wolmark N. Adjuvant therapy for colorectal cancer: the NSABP clinical trials. Adv Exp Med Biol. 1988;244:261-6doi: 10.1007/978-1-4684-5607-3_28.
Wolmark, N. (1988). Adjuvant therapy for colorectal cancer: the NSABP clinical trials. Advances in experimental medicine and biology, 244261-6. https://doi.org/10.1007/978-1-4684-5607-3_28
Wolmark, N. "Adjuvant therapy for colorectal cancer: the NSABP clinical trials." Advances in experimental medicine and biology vol. 244 (1988): 261-6. doi: https://doi.org/10.1007/978-1-4684-5607-3_28
Wolmark N. Adjuvant therapy for colorectal cancer: the NSABP clinical trials. Adv Exp Med Biol. 1988;244:261-6. doi: 10.1007/978-1-4684-5607-3_28. PMID: 3073660.
Copy Download .nbib Format: NLM
Progress report on studies of FAM-CF for gastric cancer and intraperitoneal administration of FUra-CF followed by cisplatin (DDP).

Advances in experimental medicine and biology

Arbuck SG, Douglass HO, Nava HR, Silk YN, Baroni M, Rustum YM.
PMID: 3073662
Adv Exp Med Biol. 1988;244:285-93. doi: 10.1007/978-1-4684-5607-3_31.

No abstract available.

Cite
Arbuck SG, Douglass HO, Nava HR, et al. Progress report on studies of FAM-CF for gastric cancer and intraperitoneal administration of FUra-CF followed by cisplatin (DDP). Adv Exp Med Biol. 1988;244:285-93doi: 10.1007/978-1-4684-5607-3_31.
Arbuck, S. G., Douglass, H. O., Nava, H. R., Silk, Y. N., Baroni, M., & Rustum, Y. M. (1988). Progress report on studies of FAM-CF for gastric cancer and intraperitoneal administration of FUra-CF followed by cisplatin (DDP). Advances in experimental medicine and biology, 244285-93. https://doi.org/10.1007/978-1-4684-5607-3_31
Arbuck, S G, et al. "Progress report on studies of FAM-CF for gastric cancer and intraperitoneal administration of FUra-CF followed by cisplatin (DDP)." Advances in experimental medicine and biology vol. 244 (1988): 285-93. doi: https://doi.org/10.1007/978-1-4684-5607-3_31
Arbuck SG, Douglass HO, Nava HR, Silk YN, Baroni M, Rustum YM. Progress report on studies of FAM-CF for gastric cancer and intraperitoneal administration of FUra-CF followed by cisplatin (DDP). Adv Exp Med Biol. 1988;244:285-93. doi: 10.1007/978-1-4684-5607-3_31. PMID: 3073662.
Copy Download .nbib Format: NLM
Late intensification in small-cell lung cancer: a phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Sculier JP, Klastersky J, Stryckmans P.
PMID: 2981983
J Clin Oncol. 1985 Feb;3(2):184-91. doi: 10.1200/JCO.1985.3.2.184.

We conducted a late dose intensification pilot study of small-cell lung cancer (SCLC) treated with high doses of cyclophosphamide (200 mg/kg) and etoposide (1.0 to 3.5 g/m2), administered during a period of 48 hours, as well as autologous bone...

Cite
Sculier JP, Klastersky J, Stryckmans P. Late intensification in small-cell lung cancer: a phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation. J Clin Oncol. 1985;3(2):184-91doi: 10.1200/JCO.1985.3.2.184.
Sculier, J. P., Klastersky, J., & Stryckmans, P. (1985). Late intensification in small-cell lung cancer: a phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 3(2), 184-91. https://doi.org/10.1200/JCO.1985.3.2.184
Sculier, J P, et al. "Late intensification in small-cell lung cancer: a phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 3,2 (1985): 184-91. doi: https://doi.org/10.1200/JCO.1985.3.2.184
Sculier JP, Klastersky J, Stryckmans P. Late intensification in small-cell lung cancer: a phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation. J Clin Oncol. 1985 Feb;3(2):184-91. doi: 10.1200/JCO.1985.3.2.184. PMID: 2981983.
Copy Download .nbib Format: NLM
Squamous-cell carcinoma of the anus in condyloma acuminatum. Successful treatment with preoperative chemotherapy and radiation.

Diseases of the colon and rectum

Butler TW, Gefter J, Kleto D, Shuck EH, Ruffner BW.
PMID: 3829876
Dis Colon Rectum. 1987 Apr;30(4):293-5. doi: 10.1007/BF02556178.

A 40-year-old black male had unresectable giant condylomata acuminata of the anorectum with invasive, squamous-cell carcinoma. He was treated with intravenous 5-fluorouracil and mitomycin-C and with extended field radiation to the primary lesion. An abdominoperineal resection was performed, and...

Cite
Butler TW, Gefter J, Kleto D, et al. Squamous-cell carcinoma of the anus in condyloma acuminatum. Successful treatment with preoperative chemotherapy and radiation. Dis Colon Rectum. 1987;30(4):293-5doi: 10.1007/BF02556178.
Butler, T. W., Gefter, J., Kleto, D., Shuck, E. H., & Ruffner, B. W. (1987). Squamous-cell carcinoma of the anus in condyloma acuminatum. Successful treatment with preoperative chemotherapy and radiation. Diseases of the colon and rectum, 30(4), 293-5. https://doi.org/10.1007/BF02556178
Butler, T W, et al. "Squamous-cell carcinoma of the anus in condyloma acuminatum. Successful treatment with preoperative chemotherapy and radiation." Diseases of the colon and rectum vol. 30,4 (1987): 293-5. doi: https://doi.org/10.1007/BF02556178
Butler TW, Gefter J, Kleto D, Shuck EH, Ruffner BW. Squamous-cell carcinoma of the anus in condyloma acuminatum. Successful treatment with preoperative chemotherapy and radiation. Dis Colon Rectum. 1987 Apr;30(4):293-5. doi: 10.1007/BF02556178. PMID: 3829876.
Copy Download .nbib Format: NLM
[The modern management of malignant germ cell tumor of the ovary].

Harefuah

Anteby SO, Samuelof A, Biran S.
PMID: 3038713
Harefuah. 1987 Feb 01;112(3):132-5.

No abstract available.

Cite
Anteby SO, Samuelof A, Biran S. [The modern management of malignant germ cell tumor of the ovary]. Harefuah. 1987;112(3):132-5
Anteby, S. O., Samuelof, A., & Biran, S. (1987). [The modern management of malignant germ cell tumor of the ovary]. Harefuah, 112(3), 132-5.
Anteby, S O, et al. "[The modern management of malignant germ cell tumor of the ovary]." Harefuah vol. 112,3 (1987): 132-5.
Anteby SO, Samuelof A, Biran S. [The modern management of malignant germ cell tumor of the ovary]. Harefuah. 1987 Feb 01;112(3):132-5. Hebrew. PMID: 3038713.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 109464 entries